Medtronic Takes Next Step As Heart-Failure Service Provider
The firm signaled its plan three years ago to transform itself into more of a services partner for hospitals than a product supplier. It took the latest step in that direction with the launch of service for heart-failure management, combing data from its cardiac rhythm management devices and its remote-monitoring offerings.
You may also be interested in...
Abbott Laboratories' diagnostic business is rolling out its new line of Alinity systems across its core lab, point-of-care, and molecular markets. Executive VP Brian Blaser says the systems are the realization of an ongoing customer-centric shift by the business, and the firm highlights a turnaround for a diagnostics unit that, only a decade ago, Abbott was trying to wash its hands of.
The deal gives Medtronic its first ventricular-assist devices and gives struggling HeartWare a needed boost.
Medtronic hopes the $200 million purchase of telehealth firm Cardiocom will enhance its ability to respond to increasing demands on hospitals to better manage patient outcomes and costs. It will also greatly expand its customer base.